← Back to catalogue

Architect

FDA UDI

Class II (US FDA UDI)

by Abbott Laboratories, Inc.

Identity

Trade Name
ARCHITECT FDA UDI
Generic Name
Glycated haemoglobin (HbA1c) IVD, control FDA UDI
Device Name
Hemoglobin A1c Controls FDA UDI
Model / Reference
2K96-10 FDA UDI
Description
Hemoglobin A1c Controls FDA UDI

Identifiers

Catalog Number
02K9610 FDA UDI
Primary DI / UDI-DI
00380740003616 FDA UDI
FDA Product Code
LCP FDA UDI
GGM FDA UDI
KRZ FDA UDI
GMDN Term
Glycated haemoglobin (HbA1c) IVD, control FDA UDI

Classification

Device Class
Class II FDA UDI
Regulation Number
864.7470 FDA UDI
864.8625 FDA UDI
864.8165 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

No

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

Yes

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

Yes

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

No

FDA UDI

Category: Glycated haemoglobin (HbA1c) IVD, control

Architect by Abbott Laboratories, Inc. — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Glycated haemoglobin (HbA1c) IVD, control.

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Sources (1)

  • FDA UDI 7bd57787-6a43-4342-8ea2-d20fb692ce98 36 fields · synced May 30, 2026